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CHAPTER 1 
 GENERAL INTRODUCTION 
 
Phytosterols have been studied for many years for their health benefits. In previous 
studies, an intake of 1-3 g/day of plant sterols has been shown to produce a 10-15% 
reduction in LDL cholesterol (Ling & Jones, 1995; Kritchevsky & Chen, 2005; Kuhlmann et 
al., 2005). However, the typical western diet contains only 150-400 mg/day and therefore 
does not reach desired levels to obtain the aforementioned health benefits (Ostlund, 2002). 
Consequently, supplemental doses are required.  
Previous strategies of phytosterol utilization include ultrafine powders, chemically 
modified esterified phytosterols, emulsified phytosterols, and the most susceptible to 
oxidation are phytosterols in water-oil microparticulate suspensions (Perlman, Hayes, & 
Pronczuk, 2006). These strategies, along with being susceptible to oxidation, cause 
inconvenience during processing and added costs.  
Thus, the objective of this research project included the health benefits of 
phytosterol supplementation, specifically chemically unmodified free phytosterols to 
reduce production cost in industry, as well as increase convenience in processing. 
Furthermore, the use of local soybean oil and low amounts of fully hydrogenated soybean 
oil to create a semisolid product as a substitute for partially hydrogenated fats containing 
unhealthy trans fatty acids. Puff pastry shortening typically contains high amounts of trans 
fats due its vast quantity of partially hydrogenated fats. Therefore, this study sought to 
mimic desired properties of this high-trans shortening by comparatively analyzing 
phytosterol enriched plastic fats against a commercial puff pastry shortening.
2 
CHAPTER 2 
 LITERATURE REVIEW 
 
1. Phytosterols/stanols chemical composition 
The general term ‘phytosterols’ describes plant-derived sterols and stanols with a 
chemical structure related to cholesterol, with a different side chain configuration (Cantrill, 
2008; Spitzer & Maggini, 2013) (Figure 2.1). The differentiating feature in the chemical 
structure of stanols, as compared to sterols, is the absence of a double bond at the Δ5 in the 
steroid skeleton B-ring (Spitzer & Maggini, 2013). Studies have shown that this minor 
structural difference does not have an influence in regards to clinical effectiveness 
(Hallikainen & Sarkkinen, 2000). However, stanols comprise only about 10% of total 
dietary phytosterols, and are therefore considered less significant than sterols (Spitzer & 
Maggini, 2013). Sitosterol is the most common phytosterol found in various foods, followed 
by campesterol and stigmasterol (Ostlund, 2002). 
While in humans, most of the total body cholesterol is free, plants have a much 
greater amount of total sterols in long-chain fatty acid ester form (Figure 2.2, top) 
(Kochhar, 1983). While, free phytosterols are present, they are in much smaller 
concentrations (Ostlund, Racette, Okeke, & Stenson, 2002). Besides long-chain fatty acid 
esters, phytosterols are also found in ferrulate esters in foods (Figure 2.2, middle) (Ostlund, 
Racette, Okeke, & Stenson, 2002). Glycosylated phytosterols are also a minor component in 
most foods, except in the case of potatoes where about 82% of total phytosterols are 




Figure 2.1 Common phytosterols and cholesterol structure 
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Figure 2.2 Forms of phytosterols present in plants with modifications of the 3-β-hydroxyl 
group. R represents an acyl group found in some phytosterol glycosides 
 
However, the alkaline conditions used to quantify sterols by hydrolyzing the sterol 
esters cannot cleave glycosidic linkages (Ostlund, 2002). Glycosidic linkages require acidic 
hydrolysis and therefore glycosylated phytosterols are not measured by common 
procedures for quantification of phytosterols (Ostlund, 2002).  
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It should also be noted that pancreatic enzymes could not cleave glycosylated phytosterols 
during in vitro studies, therefore their bioactivity has been doubted (Moreau & Hicks, 
2004). 
 
2. Functional Use: phytosterols 
Phytosterols are found in all plant foods, with the highest concentrations occurring 
in vegetable oils (Ostlund, 2002). Other common sources of phytosterols and stanols 
include wood pulp, leaves, nuts, seeds, and cereals (Noakes, Sullivan, Nestel, & Kritharides, 
2009). Commercially available phytosterols are obtained from the deodorized distillate 
from soybean, palm, or pine oil (Noakes et al., 2009). In general, the refining process of 
vegetable oils gradually reduces the sterol content of the oil (Kochhar, 1983). It has been 
reported that the degree of reduction differs according to the quantity of sodium 
hydroxide, type of bleaching earth, conditions of hydrogenation and steam deodorization 
time and temperature or physical deacidification (Kochhar, 1983). Overall, due to 
processing and the type of oil, a 10-70% decrease in sterols has been notable.  
For commercial use, phytosterol- and stanol powders are esterified with fatty acids 
in vegetable oils (Cantrill, 2008). The process of esterification manipulates the physical 
properties of the high melting powders that have low solubility in oils (Cantrill, 2008). The 
characteristics of the esters are similar to edible fats and oils, classified as liquid or semi-
liquid (Cantrill, 2008). The phytosterol fatty acid esters, as well as free phytosterols, are 
incorporated into processed foods such as spreads, juices, oils, and other foods. Table 2.1 
lists several food products from the United States of America and the amount of 
phytostanol esters present per serving (Cantrill, 2008). 
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Table 2.1 USA food products containing phytostanol esters; modified from (Cantrill, 2008) 
Type of Food Phytostanol ester content/daily portion (equals 2g phytostanols) 
Spread 3.4g/56g 
Dressing 3.4g/30ml 
Snack Bars 3.4g/62g 
Candy Chews 3.4g/2 candies 
Capsules 3.4g/6 capsules 
 
3. Non-esterified phytosterols  
Until recently, the majority of studies involving phytosterols or phytostanols have 
been strictly on the use of esterified phytosterols or phytostanols. There have been few 
studies addressing the use of free (non-esterified) phytosterols and phytostanols in 
commercial foods due to their limited solubility and disputes on bioavailability as 
compared to their esterified counterparts (Hayes, Pronczuk, & Perlman, 2004). 
However, researchers have proven when free phytosterols are effectively heated 
and then recrystallized in fat upon cooling, they are made bioavailable and therefore 
effective in reducing cholesterol absorption. In a study utilizing free phytosterols 
recrystallized in frying oil to create phytosterol enriched tortilla chips, researchers proved 
that even though non-esterified phytosterols have low solubility (1.5% by weight) in 
dietary fat, free sterols can be heated and recrystallized in fat during cooling to obtain a 
triglyceride-recrystallized non-esterified phytosterol complex (TRPs) (Hayes et al., 2004; 
Perlman et al., 2006). 
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The researchers of this study created a patent on the use of these TRPs. It was found 
that when TRPs are ingested, regardless of the crystalline size, they were successful at 
lowering mammalian plasma cholesterol levels (Perlman et al., 2006). The utilization of 
non-esterified phytosterols in fat, by recrystallization, lowers the cost of processing to 
make previously insoluble non-esterified phytosterols bioavailable and soluble in dietary 
fats. Previous strategies of phytosterol utilization include ultrafine powders, chemically 
modified esterified phytosterols, emulsified phytosterols, and the most susceptible to 
oxidation are phytosterols in water-oil microparticulate suspensions (Perlman et al., 2006).  
There has been much debate on the degree of cholesterol lowering by free 
phytosterols as compared to esterified phytosterols. In a study where free versus esterified 
phytosterols were used to compare cholesterol lowering abilities, a similar (60%) decrease 
was found in cholesterol absorption for both free and esterified phytosterols (Richelle et 
al., 2004). The free phytosterols also presented a lower level of α-tocopherol and β-
carotene reduction as compared to their esterified counterparts (See side effects of 
phytosterols section) (Richelle et al., 2004). Furthermore, in another study comparing free 
phytosterols versus free phytostanols, it was found that both constituents when 
supplemented in their free form result in equal LDL and total cholesterol concentrations 
(Vanstone, Raeini-Sarjaz, Parsons, & Jones, 2002). 
Data was plotted from a review combining the results of 60 clinical studies with an 
average phytosterol dose of 2.8g/day and an average LDL cholesterol reduction of 10.9% 




Despite previous controversy addressing free phytosterol bioavailability, the results from 
the plotted studies indicate free phytosterols/stanols had a slightly higher level of 
cholesterol lowering ability than phytosterol/stanol esters (Normen et al., 2004).  
 
4. Stability of phytosterol, phytostanols, and their fatty acid esters 
Typically, phytosterols and their fatty acid esters are stable compounds, but in the 
presence of oxygen under conditions such as high temperatures (>100°C), oxidation can 
occur (Cantrill, 2008). These conditions can occur during shallow frying of foods in 
phytosterol oils (Cantrill, 2008). In shallow frying, temperatures range from 160-200°C for 
5-10 minutes (Cantrill, 2008). However, even at these harsh conditions phytosterol esters 
in liquid margarine remained below 1.3% oxidation levels (Cantrill, 2008). Most 
phytosterols and ester oil products on the market are typically low fat spreads with less 
than 40% total fat (Cantrill, 2008). These products are made for spreading, not with the 
intention for use in shallow frying (Cantrill, 2008). Phytosterol enriched spreads with 
higher levels of fat, greater than 60% total fat are intended for use in shallow frying, but 
still not for the more severe conditions of deep fat frying (Cantrill, 2008). 
Concerning free versus phytosterol esters, the esters were found to be more 
susceptible to oxidation at higher temperature conditions than free phytosterols (Cantrill, 
2008). Phytostanols and phytostanol esters are also relatively heat stable and show low 
oxidation (Cantrill, 2008). Other food processing and long-term storage conditions for 
phytosterols that can influence the autoxidation free-radical process include light, water or 
metal exposure (Soupas, Huikko, Lampi, & Piironen, 2006).  
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These same conditions along with quality of packaging and packaging materials could lead 
to sterol oxidation in long-term storage (Soupas et al., 2006).  
 
In regards to microbiological stability, phytosterols and phytostanols are inactive as 
shown by no effect on yogurt processing in the fermentation steps (Cantrill, 2008). Not 
only do phytosterol and phytostanol esters show stability in products with large quantities 
of active bacteria like yogurt and yogurt-based beverages, they also have shown stability in 
milk and fermented milk (Cantrill, 2008). In long term storage, up to one year, phytostanol 
and phytosterol ester products show superior stability at various pH values (Cantrill, 
2008). 
 
5. Regulations on phytosterols 
Official health claims and safety guidelines have been established addressing the use 
of phytosterols and phytosterol containing foods that are low in saturated fat and 
cholesterol as an option in lowering cholesterol levels (Spitzer & Maggini, 2013). The use of 
phytosterols as supplement to lower cholesterol has been well studied. More than 80 
studies have been conducted with the use of phytosterols, and no major adverse effects 
have been reported (Spitzer & Maggini, 2013). The U.S. Food and Drug Administration 
(FDA) issued an official health claim regarding phytosterols in the year 2000 and has also 
recognized phytosterol esters as safe ingredients as long as a ‘self-GRAS’ (Generally 




The approval of phytosterols in functional foods and supplements has been achieved 
outside of the United States as well, such as in the European Union (EU), Australia, 
Switzerland, Norway, Iceland, Brazil, South Africa, Japan, Turkey, and Israel (Spitzer & 
Maggini, 2013). 
 
6. Side effects from phytosterol supplementation 
A rare genetic disorder (approximately one in 6 million) associated with phytosterol 
absorption termed sitosterolemia or phytosterolemia is caused by mutations in the genes 
encoding the ABCG5 and ABCG8 cholesterol transport proteins (Noakes et al., 2009; Spitzer 
& Maggini, 2013). This mutational genetic disorder is characterized by promoting an 
increased absorption of phytosterols and cholesterol, resulting in an elevated risk for CHD 
for patients with this disorder (Patel & Thompson, 2006; Noakes et al., 2009). However, 
studies with the more common heterozygous carriers of the mutation showed that no 
abnormally elevated serum phytosterols could be observed after consumption of 3 g/day of 
phytosterols for 4 weeks and 2.2 g/day of phytosterols for 6–12 weeks (Spitzer & Maggini, 
2013). The genetic disorder is rare and involves defective cholesterol as well as phytosterol 
transport, so it may not be directly relevant to phytosterol intake (Kwiterovich et al., 2003).  
In regards to maximum dosages on effectiveness for cholesterol lowering, 
phytosterol intake which exceeded 3 g/day did not show any additional benefits (SFC, 
2003). Long term studies have proven phytosterols to be well tolerated when consumed 
every day over the span of several months (Spitzer & Maggini, 2013). A few minor side 
effects have been reported in rare cases such as slight gastrointestinal discomfort including 
gas, diarrhea, and constipation (St-Onge & Jones, 2003). 
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Intestinal bacteria and male and female hormone levels are not affected by 
phytosterols (Hendriks, Brink, Meijer, Princen, & Ntanios, 2003; Spitzer & Maggini, 2013). 
However, there have not been any studies addressing the consumption of phytosterols 
during pregnancy in regards to safety and toxicity for the fetus (Spitzer & Maggini, 2013). 
Also, phytosterols have been proven to reduce β-carotene levels, which is of concern for 
populations with greater vitamin A needs, such as pregnant and lactating women (Richelle 
et al., 2004). Therefore, phytosterols are not yet recommended for pregnant or breast-
feeding women (Spitzer & Maggini, 2013). 
There are conflicting results on the effects of consumption of phytosterols on the 
resulting concentrations of fat-soluble vitamins. Fat-soluble vitamins and fat-soluble 
micronutrients known as carotenoids are transported by lipoproteins; lipoproteins are 
lowered by the consumption of phytosterols (Spitzer & Maggini, 2013). In a study involving 
phytosterol esters ingested in the form of a spread up to 1 year at 1.6g/day, plasma vitamin 
A concentrations did not drop (Hendriks et al., 2003). However, in the same study a slight 
but statistically significant decrease (7%) in plasma 25 hydroxyvitamin D3 concentrations 
could be detected (Hendriks et al., 2003). The study also proved Vitamin E levels 
diminished slightly, however those decreases are not relevant when plasma alpha-
tocopherol concentrations are standardized to the concentration of LDL in cholesterol 
(Hendriks et al., 2003). In regards to vitamin K, studies have shown an absence of 
information providing a significant decrease in concentrations when consuming 
phytosterols (Raeini-Sarjaz, Ntanios, Vanstone, & Jones, 2002).  
Even after standardizing carotenoid levels to LDL cholesterol concentrations, some 
studies have indicated consumption of phytosterols may lead to a 10–20% reduction in 
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plasma carotenoids (Ntanios & Duchateau, 2002). Further studies are needed to prove if 
this decrease will cause any health risks.  However, researchers have noted that the 
reduced levels of carotenoids can be prevented by increasing the dietary intake of fruits 
and vegetables (Ntanios & Duchateau, 2002). It should also be noted that in a study 
comparing free versus esterified phytosterols on the reduction of α-tocopherol and β-
carotene, free phytosterols had significantly lower levels of reduction (Richelle et al., 2004).  
A possible explanation for the esters having a greater effect on fat-soluble vitamins 
and micronutrients, is that in the intestine, esters disperse into the oil phase whereas free 
sterols move into the micellar phase (Nissinen, 2002). 
 
7. Cardiovascular Disease 
 The number one cause of death worldwide is cardiovascular disease (CVD) (WHO, 
2011). In 2008, an estimated 17.3 million people died from CVD and by the year 2030 it is 
predicted that this number will grow to 23.3 million (WHO, 2011). Additionally, CVD 
comprises 17% of overall national health expenditures (Heidenreich et al., 2011). Total 
direct medical costs of CVD from 2010 to 2030 are expected to triple, from $273 billion to 
$818 billion (Heidenreich et al., 2011). Therefore, it is crucial to reduce the risk of CVD, 
ultimately reducing overall health care expenses. 
There is a plethora of research proving dietary saturated and trans fats lead to an 
elevated LDL to HDL ratio and total cholesterol in the blood (Noakes et al., 2009). 
Hypercholesterolemia, a precursor for atherosclerosis, is a significant contributor in the 
development of cardiovascular disease (Noakes et al., 2009).  
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Plaque buildup on artery walls, from a diet high in cholesterol, restricts normal levels of 
blood flow in the artery, causing the heart to work harder to pump and circulate blood 
throughout the body.  
 
8. Trans fats 
 Trans fatty acids ascend from either industrial hydrogenation, or from the natural 
process of biohydrogenation in ruminant animals (Brouwer, Wanders, & Katan, 2010). In 
industrial hydrogenation, partial hydrogenation of vegetable or fish oils with the use of 
hydrogen in the presence of a metal catalyst is used to produce trans fatty acids (Brouwer 
et al., 2010). Trans fatty acids naturally present in the rumens of cows and sheep, which are 
present in the fat in milk, butter, cheese, and beef, are produced from partial hydrogenation 
and/or isomerization of cis-unsaturated fatty acids from the feed (Brouwer et al., 2010). 
Hydrogen and a catalyst are still necessary for the formation of trans fatty acids in nature. 
However, the hydrogen in this process is produced during oxidation of substrates and 
bacterial enzymes are used as catalysts (Brouwer et al., 2010). 
 In industrial production of trans fats, the process of hydrogenation with a catalyst 
converts previously liquid vegetable and fish oils into semisolid fats. These semisolid fats 
are then used in margarines, commercial cooking, and manufacturing processes in the food 
industry (Mozaffarian, Katan, Ascherio, Stampfer, & Willett, 2006). For use in food 
applications, partially hydrogenated oils are attractive because of their lengthy shelf life, 
stability under harsh conditions such as deep-frying, and their semisolidity, which can be 
utilized to heighten the palatability of baked goods and sweets (Mozaffarian et al., 2006). 
14 
Studies have shown that the consumption of industrial produced trans fatty acids increases 
the LDL to HDL ratio of total cholesterol in the blood, and therefore raising the risk of 
coronary heart disease (Mozaffarian et al., 2006). In fact as of January 2006, the FDA 
changed the Nutrition Facts panel regulations stating that products containing trans fat 
must be labeled to include the amount of trans fat content (FDA, 2006). This modification 
was done to assist consumers in choosing heart-healthy foods (FDA, 2006).  Common 
sources of trans fats include deep-fried fast foods, bakery products, processed snack foods, 
margarines, and crackers (Mozaffarian et al., 2006). 
 
9. Cholesterol reduction medications 
Statins are the most common type of drugs prescribed to control high cholesterol 
levels in patients. The interference with the production of endogenous cholesterol by the 
liver is responsible for the cholesterol lowering mechanism of statins (Normen, Holmes, & 
Frohlich, 2005; Spitzer & Maggini, 2013) The main enzyme responsible for endogenous 
cholesterol synthesis, hydroxy-methylglutaryl-coenzyme A reductase, is blocked by statins 
(Stancu & Sima, 2001; Normen et al., 2005). The process by which phytosterols and statins 
lower cholesterol is different; therefore when both compounds are taken collectively 
cholesterol reduction can be elevated (Spitzer & Maggini, 2013). Clinical studies using 
statins and phytosterols in combination have validated that the addition of phytosterols to 
a statin regimen can reduce LDL levels by an additional 4.5% per gram of ingested 
phytosterol (Normen et al., 2005). This overall level of phytosterol and statin combined 
reduction is analogous to the level achieved by doubling the prescribed statin dose 
(Normen et al., 2005).  
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This knowledge is beneficial due to statins having unwanted side effects caused by 
their interference with the rate-limiting step in endogenous cholesterol production 
(Normen et al., 2005). Statins work by interfering with HMG-CoA reductase, which is 
synthesized from mevalonate. Mevalonate also has a key role in the synthesis of several 
compounds such as coenzyme Q10 (CoQ10) (Ghirlanda & Caputo, 1993). The reduction of 
CoQ10 caused by statins can lead to possible cellular damage due to its pertinent role in the 
electron transport chain and role as an effective lipid-soluble antioxidant (Ghirlanda & 
Caputo, 1993). 
 
10. Phytosterols and cholesterol reduction 
Even though the human diet contains almost equal proportions of cholesterol and 
phytosterols, it seems greater than 95% of dietary phytosterols undergo straight fecal 
excretion while about 50% of dietary cholesterol is absorbed (Spitzer & Maggini, 2013). 
These findings suggest that the human body is capable of differentiating between 
cholesterol and non-cholesterol phytosterols (Spitzer & Maggini, 2013). Greater intake of 
phytosterols is necessary to compete for absorption against cholesterol. The competitive 
mechanism between phytosterols and cholesterol are still being further studied. Some 
researchers have proposed possible effects at the absorption site, physico-chemical effects, 
and controlling intracellular trafficking of sterols (Spitzer & Maggini, 2013).  
Dietary cholesterol, when consumed, is incorporated into mixed micelles formed in 
the small intestine. These mixed micelles are responsible for transporting cholesterol 
across the intestinal lumen comprised of enterocytes. If phytosterols and cholesterol are 
collectively consumed, competition at the absorption site occurs due to the similar 
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chemical structures (Spitzer & Maggini, 2013). As phytosterols are incorporated into mixed 
micelles over cholesterol, any free cholesterol gets excreted in the feces because 
cholesterol in its free form cannot be absorbed. After undergoing micelle formation, the 
esterified phytosterols are hydrolyzed to free phytosterols presumably by enzymes 
cholesterol esterase and pancreatic lipase (Normén et al., 2006). Another proposed 
mechanism, of less significance, is a co-crystallization process with the formation of an 
insoluble mixed phytosterol-cholesterol crystal that can no longer pass through the 
intestine lumen (Mel’nikov, Seijen ten Hoorn, & Bertrand, 2004).   
 
A cyclic mechanism has been proposed regarding a transporter protein involved in 
the absorption of phytosterols and cholesterol. The Niemann-Pick C1L1 transporter assists 
in the absorption of cholesterol and phytosterols at the enterocyte (Spitzer & Maggini, 
2013). Once inside the enterocyte, adenosine triphosphate (ATP)-binding cassette proteins 
are induced through the presence of phytosterols (Spitzer & Maggini, 2013). The ABC 
transporters use energy produced from ATP hydrolysis to assist cholesterol and 
phytosterols across the membrane (Spitzer & Maggini, 2013). The increase in ABC 
transporters from a high intake of phytosterols has been studied as a main constituent in 
the cholesterol-lowering effect. The ABC transporters in the enterocytes secrete 
phytosterols and free cholesterol back into the intestinal lumen where the cycle continues 
for the sterols to get incorporated into the mixed micelles, continuing to get taken back up 
by the enterocytes again (Calpe-Berdiel, Escolà-Gil, & Blanco-Vaca, 2009). Phytosterols are 
secreted back into the intestinal lumen at a much higher rate than cholesterol, therefore 
supplementation is needed for an increased absorption (Spitzer & Maggini, 2013). 
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After phytosterols and cholesterol are taken up by the enterocytes, they must be 
incorporated into chylomicrons for further transport throughout the body. However, 
phytosterols must undergo esterification for the further integration into chylomicrons. 
Phytosterols are not esterified as efficiently as cholesterol, this rate limiting step in the 
competition between phytosterols and cholesterol leads to smaller concentrations of 
phytosterols reaching the tissues (Spitzer & Maggini, 2013). The liver takes up the 
phytosterols that do end up getting transported by chylomicrons where they are quickly 
excreted into bile by hepatic ABCG5/G8 transporters. Cholesterol also undergoes this same 
process. However, the secretion rate of phytosterols into the bile is much higher than 
cholesterol (Sudhop & von Bergmann, 2002). Cholesterol excreted into the bile is either 
reabsorbed or further excreted into the feces. The increased consumption of phytosterols 
with the intention of displacing cholesterol reduces reabsorption of cholesterol through the 
bile. When there is a decrease in levels of cholesterol, LDL-receptor expression is increased. 
This results in an increase of LDL clearance in circulation (Ostlund, 2007). 
 
11. Phytosterols and cancer prevention 
 In addition to their cholesterol-lowering benefits, numerous studies on phytosterols 
indicate an anti-cancer effect as well (Choi et al., 2007). Research has revealed protective 
effects against cancer of the lung (Mendilaharsu, De Stefani, Deneo-Pellegrini, Carzoglio, & 
Ronco, 1998), stomach (De Stefani et al., 2000), ovary (McCann, Freudenheim, Marshall, & 
Graham, 2003), as well as estrogen-dependent human breast cancer (Ju, Clausen, Allred, 
Almada, & Helferich, 2004).  
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Researchers have proposed various anti-cancer effects from phytosterols such as the 
inhibition of carcinogen production, cancer-cell growth, invasion and metastasis, and the 
promotion of cancer cell apoptosis (Méric et al., 2006). 
Carcinogenesis, from damaged DNA, occurs from reactive oxygen species produced 
by oxidatively stressed cells (Woyengo, Ramprasath, & Jones, 2009). Phytosterols work to 
protect against reactive oxygen species by increasing the activity of antioxidant enzymes 
such as superoxide dismutase and glutathione peroxidase (Vivancos & Moreno, 2005). In 
regards to cancer cell growth, a study done on the treatment of leukemia cells, breast 
cancer cells, and prostate cancer with β-sitosterol all showed a significant decrease in cell 
growth (Park et al., 2007). Another study involving β-sitosterol determined the mechanism 
by which phytosterols promote apoptosis of cancer cells. It seems the treatment of human 
leukemia cells with β-sitosterol resulted in an increased activity of an essential protein 
involved in cell death, caspase-3 (Park et al., 2007). In the invasion of cancer cells, 
angiogensis, while important in wound healing, also has a major role in increased cancer 
cell growth and multiplication (Prescott, 2000). Metastasis, or the spreading of cancer 
throughout the body’s organs, is the main cause of death following cancer diagnosis (Awad, 
Fink, Williams, & Kim, 2001). Phytosterols have been proven to have an effect on both of 
these cancer-promoting events, and the mechanisms by which the phytosterols interfere 
are still under investigation. 
 
12. Soybean oil and fully hydrogenated soybean oil 
 The use of fully hydrogenated oil eliminates all trans fatty acids. Full hydrogenation 
and likewise saturation of the fatty acid does not allow a shift from the cis to trans 
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configuration, unlike in partially hydrogenated oils. Alternatives to achieve the semisolid 
consistency of partially hydrogenated oils includes utilizing blends of fully hydrogenated 
oils with liquid oils to create a semisolid product with zero trans fat. 
 Due to current recommendations to decrease trans and saturated fats, there is a 
demand to find appropriate solid fat substitutes that do not increase the risk for CVD 
(Hunter, Zhang, & Kris-Etherton, 2010). One saturated fat in particular, fully hydrogenated 
soybean oil, has a fatty acid profile high in stearic acid (18:0) at ~84% (Acevedo, Block, & 
Marangoni, 2012). Stearic acid has been under investigation for its use in saturated fats.  
In a study comparing effects on serum lipoproteins between stearic acid and trans 
fatty acid, 80 healthy subjects consumed a dairy fat-based diet as a baseline, then an 
experimental diet high in either stearic acid (Aro, Jauhiainen, Partanen, Salminen, & 
Mutanen, 1997). When compared with the dairy fat diet, similarly both stearic and trans 
fatty acids decreased total serum cholesterol concentrations by 13% and 12% (Aro et al., 
1997). However, the trans fatty acid diet decreased HDL cholesterol by 17% while stearic 
acid only decreased HDL cholesterol by 11% (Aro et al., 1997). In regards to lowering 
harmful LDL cholesterol, only the stearic acid diet decreased LDL concentrations 
significantly (Aro et al., 1997). In fact, the trans fatty acid diet increased the harmful LDL to 
HDL ratio by 19% as compared to the dairy fat baseline diet (Aro et al., 1997). Altogether, 
the outcomes from the stearic acid diet emerged to be less harmful than those of the trans 
fatty acid diet. 
Furthermore, the utilization of locally produced oils such as soybean oil can reduce 
costs and boost local economy instead of importing foreign oils. In fact, the United States is 
the largest producer and exporter of soybeans in the world (USDA, 2012). 
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13. Research justification 
 The justification of this research project includes the health benefits of phytosterol 
supplementation, specifically chemically unmodified free phytosterols to reduce 
production cost in industry, as well as increase convenience in processing. Furthermore, 
the use of local soybean oil and low amounts of fully hydrogenated soybean oil to create a 
semisolid product as a substitute for partially hydrogenated fats containing unhealthy 
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ANALYSIS OF CO-CRYSTALLIZED FREE PHYTOSTEROLS WITH TRIACYLGLYCEROLS AS 




Free phytosterols (FPS) have been utilized in recent research compared to their 
esterified or soluble counterparts in order to reduce costs and inconvenience associated 
with esterified phytosterols during processing. Furthermore, bans on trans fats have led to 
the need for substitutes that can mimic their desirable properties. This research focuses on 
the analysis of FPS co-crystallized with fully hydrogenated soybean oil (FHSO) and soybean 
oil (SO) as a zero-trans substitute for puff pastry shortening and various other types of 
shortenings. Differential interference contrast microscopy and wide angle x-ray diffraction 
demonstrated co-crystallization of FPS with FHSO and SO. Polymorphic forms were 
characterized as β’ and β for all samples. The addition of FPS decreased oil loss (OL) and 
melting profiles of FPS samples were extended to higher temperatures compared to 
commercial puff pastry shortening. Rheological properties suggested FPS blends may be 
acceptable for bakery applications. With further research, FPS co-crystallized with FHSO 
and SO may be used as a suitable trans-fat free substitute for several types of shortening, 






• Co-crystallized free phytosterol triacylglycerol blends as a substitute for trans fat 
containing puff pastry shortenings 
• Free phytosterol triacylglycerol blends are in desirable polymorphic forms 
• Free phytosterols decrease oil loss in triacylglycerol blends 




FHSO Fully Hydrogenated Soybean Oil 
SO Soybean Oil 
FPS Free Phytosterol 
β-Sit. β-Sitosterol 
Stig. Stigmasterol 
DSC Differential Scanning Calorimetry 
NMR Nuclear Magnetic Resonance 
WXRD Wide Angle X-Ray Diffraction 
DIC Differential Interference Contrast 







Phytosterols are found in all plant foods, with the highest concentrations occurring 
in vegetable oils (Ostlund, 2002). The general term ‘phytosterols’ describes plant-derived 
sterols and stanols with a chemical structure related to cholesterol and having a different 
side chain configuration (Cantrill, 2008; Spitzer & Maggini, 2013). Even though the human 
diet contains almost equal proportions of cholesterol and phytosterols, it seems greater 
than 95% of dietary phytosterols undergo straight fecal excretion while about 50% of 
dietary cholesterol is absorbed (Spitzer & Maggini, 2013). These findings suggest that the 
human body is capable of differentiating between cholesterol and non-cholesterol 
phytosterols (Spitzer & Maggini, 2013). In previous studies, an intake of 1-3 g/day of plant 
sterols has been shown to produce a 10-15% reduction in LDL cholesterol (Ling & Jones, 
1995; Kritchevsky & Chen, 2005; Kuhlmann et al., 2005). However, the typical Western diet 
today contains only 150-400 mg/day (Ostlund, 2002). Therefore, greater intake of 
phytosterols is necessary to compete for absorption against cholesterol and supplemental 
doses may be required.  
For commercial use, phytosterol- and stanol powders are esterified with fatty acids 
in vegetable oils (Cantrill, 2008). The process of esterification manipulates the physical 
properties of the high melting powders that have low solubility in oils (Cantrill, 2008). The 
characteristics of the esters are similar to edible fats and oils, classified as liquid or semi-
liquid (Cantrill, 2008). The phytosterol fatty acid esters are incorporated into processed 
foods such as spreads, juices, oils, and other foods.  
Until recently, the majority of studies involving phytosterols or phytostanols have 
been strictly on the use of esterified phytosterols or phytostanols. There have been few 
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studies addressing the use of free (non-esterified) phytosterols and phytostanols in 
commercial foods due to their limited solubility and disputes on bioavailability as 
compared to their esterified counterparts (Hayes et al., 2004). However, researchers have 
proven when free phytosterols are effectively heated and then recrystallized in fat upon 
cooling, they are made bioavailable and therefore effective in reducing cholesterol 
absorption (Hayes et al., 2004; Perlman et al., 2006). The utilization of non-esterified 
phytosterols in fat, by recrystallization, lowers the cost and increases convenience of 
processing to make previously insoluble non-esterified phytosterols bioavailable and 
soluble in dietary fats (Hayes et al., 2004). Previous strategies of phytosterol utilization 
include ultrafine powders, chemically modified esterified phytosterols, emulsified 
phytosterols, and the most susceptible to oxidation are phytosterols in water-oil 
microparticulate suspensions (Perlman et al., 2006).  
The justification of this research includes the health benefits of phytosterol 
supplementation. Furthermore, the use of local soybean oil and low amounts of fully 
hydrogenated soybean oil to create a semisolid product as a substitute for various bakery 
shortenings. Puff pastry shortening was specifically selected due to the large amount of 
partially hydrogenated fats present in the product. Partially hydrogenated fats are a major 
source of unhealthy trans fatty acids. Due to current recommendations to decrease trans 
fats, there is a demand to find appropriate solid fat substitutes that do not increase the risk 





2. Materials and Methods 
2.1. Materials 
Fully hydrogenated soybean oil (FHSO) and liquid soybean oil (SO) were generously 
donated from ADM oils (Decatur, IL). Beta-sitosterol powder (purity ≥70 %) was obtained 
from Sigma-Aldrich (St. Louis, MO). Stigmasterol powder (purity > 90%) was obtained 
from TCI America (Portland, OR). Super Bowl® puff pastry shortening consisting of 
partially hydrogenated soybean oil and cottonseed oils with artificial flavor and artificial 
colors was generously provided by Stratas Foods (Memphis, TN). 
 
2.2 Blend preparation 
Samples consisted of 48% solids and 52% liquid oil. For free phytosterol (FPS) fat 
blends, the solid material consisted of either 20% or 25% FPS and 28% or 23% FHSO 
(totaling 48%); the 52% liquid portion consisted of soybean oil. The control sample 
contained 0% FPS, 48% FHSO, and 52% soybean oil. Blends were prepared by heating the 
mixture up to ~180°C and agitating with a Caframo Real Torque Digital overhead stirrer 
(Ontario, Canada) at 200 RPM. Once the mixtures were clear, they were held at 180°C for 
additional 20 minutes to ensure the crystal memory had been erased. Subsequently, all 
samples were cooled at room temperature until ~20°C was reached and once 
crystallization was complete they were stored at 4°C until use in analysis. 
 
2.3. Wide Angle X-ray Diffraction (WAXRD) 
Wide angle x-ray diffraction (WAXRD) patterns of crystallized FPS, FPS fat blends, 
and control fat blends were measured using a Rigaku Ultima (Rigaku, Japan) IV X-ray 
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diffractometer. The operating conditions during experiments were 44 mA and 40kV. The 
angular range using a 10 mm slit was from 1 to 30° (2θ) with steps of 1°, and the measuring 
time was 1 minute/step. XRD patterns were analyzed with MDI Jade 9.0 software (Rigaku, 
Japan). In this study, three replicates of each sample were performed. 
 
2.4. Differential Scanning Calorimetry (DSC) 
The thermal properties of phytosterol and control samples were measured by 
differential scanning calorimetry (DSC) using a Perkin Elmer Diamond DSC (Shelton, CT, 
USA). Heat flow calibration was made by reference to the known melting enthalpy of 
indium (purity >90 %). Temperature calibration was made with zinc (purity >90 %). 
Approximately 10mg of sample was placed in aluminum pans and sealed hermetically, an 
empty pan served as a reference. All measurements were performed at a heating rate of 
10°C/min. Thermograms were analyzed using Pyris Series Diamond DSC 9.0 software 
(Shelton, CT, USA). The peak melting temperature (Tm) and the enthalpy of melting (ΔHm) 
were determined. The reported data corresponds to the average of three replicates of each 
sample. 
 
2.5. Proton-Nuclear Magnetic Resonance (1H-NMR) 
Solid fat content (SFC) was analyzed by proton nuclear magnetic resonance (1H-
NMR) by using a Bruker MiniSpec Bench Top NMR (Billerica, MA, USA). Co-crystallized 
samples stored at 4°C were introduced into NMR glass tubes, then incubated for 30 
minutes at 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100°C to allow for a homogenous 
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distribution of temperature at the time of measurement. The reported data correspond to 
the average of three replicates of each sample. 
 
2.6. Oil Loss Determination (OL) 
Once crystallized, oil loss (OL) experiments were performed according to previously 
described techniques (Dibildox-Alvarado, Rodrigues, Gioielli, Toro-Vazquez, & Marangoni, 
2004; Acevedo et al., 2012). Blends were molded into PVC molds of 35 mm diameter and 
3.2 mm thickness to form disks that were then transferred to filter papers (Whatman #1, 
125 mm diameter). The amount of oil lost over time was determined by the difference in 
weight of the filter papers before and after placing the disc on the paper for the designated 
time at 20°C. A “blank” filter paper was included in all experiments to account for 
differences in possible humidity of the storage environment. Filter papers were large 
enough to avoid paper saturation with oil during the experiment. The reported data 
correspond to the average and standard deviation of five replicates, each separate disk on 
an individual filter paper. Oil loss (%) was calculated according to previously described 
technique and OL rate (g/h) was calculated from the average slope of OL replicates of each 
sample:  
     OL(%) = 
.	 .  
.  
 X 100                       
 
2.7. Differential Interference Contrast Microscopy (DIC) 
Differential Interference Contrast (DIC) Microscopy was used to observe the FPS fat 
blends microstructure. Approximately 0.01 g of the melted sample was placed on a heated 
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glass slide and a heated glass cover was carefully laid over the sample to remove air and 
homogenously spread the sample. After cooling at room temperature 20°C, slides were 
stored at 4°C until analysis. Samples were imaged using an Olympus BX53 System 
Microscope (Tokyo, Japan) with polarized light (X-Cite 120 LED) and equipped with an 
Olympus Q Imaging camera. All images were obtained using a 40X objective lens. 
Autoexposure of the camera was adjusted according to the sample. CellSens Dimension 1.9 
software (Tokyo, Japan) was used to acquire focused images. At least twenty-five images in 
total were captured from each of the 9 replicates.  
 
2.8. Small Deformation Rheology 
Crystallized samples were spread into the wells of polyvinylchloride (PVC) molds of 
3.2 mm thick and 35 mm in diameter. Rheological measurements were obtained using a 
HAAKE RS 150 RheoStress rheometer (Paramus, NJ, USA). A 35 mm diameter serrated 
stainless steel plate (PP35Ti) was used in the analysis. Each sample was kept at a constant 
temperature 20°C controlled by the base of the TC 81 Peltier temperature control system 
through a HAAKE F6 (Paramus, NJ, USA) water bath. 
 Oscillatory stress sweeps were performed within the range of 50 to 2000 Pa (with a 
frequency of 1 Hz) inside the linear viscoelastic region (LVR). Normal force was set at 3N 
for all samples. Sandpaper (grade 60) was attached to the base of the rheometer to prevent 
slippage of samples during analysis. The yield stress (σ*) values (Pa), elastic (G’) and 
storage (G’’) modulus values (MPa) were determined from the stress sweep curves. The 
reported data are the average of eight individual replicates from each sample. 
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2.9. Statistical Analysis 
GraphPad Prism 5 software (GraphPad Software, Inc., San Diego, CA) was used to 
process data. Reported values correspond to means and standard deviations of the 
measurements. Statistical analysis was carried out by one-way ANOVA (P < 0.005) with 
Tukey’s multiple comparisons as a post-test (P < 0.05).  
 
3. Results and Discussion 
3.1. Analysis of thermal properties 
 DSC is a well-established method conducted to assess the thermal properties of fats 
and oils during heating and cooling. Thermograms showed the melting point Tm range 
between 63.02-65.36°C for the 48:52 FHSO:SO (control sample) and all FPS fat blend 
samples, i.e. 20:28:52 β-Sit:FHSO:SO, 25:23:52 β-Sit:FHSO:SO, 20:28:52 Stig:FHSO:SO and 
10:10:28:52 β-Sit:Stig:FHSO:SO (Table 3.1); which is in agreement with previous studies on 
FHSO:SO blends (Acevedo et al., 2012). Thermograms also showed Tm for β-sitosterol 
powder of 137.78°C in agreement with (Vaikousi, Lazaridou, Biliaderis, & Zawistowski, 
2007) and stigmasterol powder of 169.99°C. In FPS fat blends, no peaks were observed at 
temperatures corresponding to the (Tm) of FPS powders suggesting co-crystallization of the 
species (Figure 3.1). The type of FPS appears to have affected the enthalpy of melting (∆H) 
(Table 3.1). The addition of 20% β-sitosterol or stigmasterol reduced ∆H by 32.71% and 
29.73% respectively when compared to the control. However, when both β-sitosterol and 
stigmasterol were added to the FHSO:SO fat blends (10:10:28:52 β-Sit:Stig:FHSO:SO), ∆H 
was not significantly different from the control. These results may be indicating 
interference by FPS in the thermodynamic system. 
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Figure 3.1 DSC thermograms of the fat blends with and without FPS as well as pure FPS 
 
Under thermal conditions such as in DSC, the heat given off by the system is 
proportional to the internal energy occurring in the reaction (Durland, 2015). The addition 
of both FPS in FHSO:SO blends could have generated greater internal energy in the system, 
resulting in a higher enthalpy of melting. However, when only one type of FPS was added to 
the fat blends, the internal energy of the system was lower, thus a lower enthalpy of 
melting was found. Thus, the sample containing both types of FPS had a higher enthalpy of 
melting than the sample containing only one type of FPS. 
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Table 3.1 Melting temperature (Tm) and enthalpy of melting (∆H) of the control sample, 
pure phytosterols and their blends 
Sample Tm (°C) ± SD ∆H (J/g) ± SD 
48:52 FHSO:SO 65.30 ± 2.50a 71.88 ± 6.90a 
20:28:52 β-Sit:FHSO:SO 63.02 ± 2.00a 48.37 ± 6.43b  
25:23:52 β-Sit:FHSO:SO 63.05 ± 0.17a 41.18 ± 2.74b 
20:28:52 Stig:FHSO:SO 65.36 ± 0.72a  50.51 ± 7.37b  
10:10:28:52 β-Sit:Stig:FHSO:SO 63.07 ± 0.37a 86.64 ± 8.14a 
β-Sitosterol 137.78 ± 0.79b 43.27 ± 4.34b 
Stigmasterol 169.99 ± 1.54c  72.80 ± 4.64a  
Note: Different letters within columns indicate statistical difference at 5% probability level 
 
3.2. Polymorphic form characterization 
Polymorphic form characterization is important to assess the stability of fats and 
oils. WAXRD patterns of the control consisting of 48:52 FHSO:SO and all FPS fat blend 
samples showed a presence of both polymorphs β’ and β (Figure 3.2a, b and c) (Sato, 2001). 
However, XRD patterns from the control showed greater characteristics of β 
polymorphism, which is in agreement with previous studies on FHSO:SO blends (Acevedo 
et al., 2012). Furthermore, β-sitosterol d-values were in agreement with previous research 
(Christiansen, Rantanen, von Bonsdorff, Karjalainen, & Yliruusi, 2002; von Bonsdorff-
Nikander, Karjalainen, Rantanen, Christiansen, & Yliruusi, 2003). However, there is a lack 
of previous studies performed to assess the nanostructure of stigmasterol using WAXRD.  
37 
 
Figure 3.2 Wide angle x-ray diffraction (WAXRD) patterns of control (a), β-sitosterol and its 
mixture with FHSO:SO (b), and stigmasterol and its mixture with FHSO:SO (c). d-values of 
possible new structures formed in free phytosterol fat blends as compared to free 
phytosterols are indicated with arrows (b and c) 
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Polymorphic form is predominately determined by the rate of nucleation, being 
governed by thermodynamic and kinetic influences (Sato, 2001). When nucleation is 
induced under sizeable kinetic factors, e.g., supercooling or supersaturation the metastable 
form nucleates first prior to the most stable form (Sato, 2001). However, when some other 
external influences (pressure, temperature fluctuation, ultrasonic stimulation, template, 
seeding, etc.) are applied the nucleation of the more stable forms is hindered (Sato, 2001; 
Rousseau, Hodge, Nickerson, & Paulson, 2005). It appears the addition of FPS as an external 
influence into the FHSO:SO system is impeding the polymorphism transition from the 
metastable form β’ to most stable β. The addition of FPS may be kinetically entrapping the 
crystals in the metastable form due to the higher viscosity of the system, preventing the 
polymorphic transformation toward the more stable form.  
There is a lack of literature on this topic to elucidate the nanostructure of FPS 
crystallized with FHSO:SO blends. However, the XRD patterns of FPS fat blends presented 
new d-values absent in the control or FPS powder XRD patterns (Figure 3.2b and c). These 
new d-values, indicated with arrows, could be attributed to the presence of new structures 
formed by co-crystallization of FPS with triacylglycerols, also suggested by DSC 
thermograms (Figure 3.1). Further analysis needs to be carried out to elucidate the 
nanostructure of these matrices. 
 
3.3. Microstructure analysis by DIC 
Differential interference contrast (DIC) microscopy was used for microstructural 
analysis due to the polarized light microscope’s ability to exploit the high contrast between 
the solid and liquid fraction in fats and oils (Murphy, 1998). Fig. 3.3 shows digitalized 
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images of samples thermostatically crystallized at 20 °C. The microstructure of the control 
sample consisted of aggregated spherulites, similar to previous research where similar fat 
blends were analyzed (Acevedo et al., 2012; Bouzidi, Omonov, Garti, & Narine, 2013). The 
morphology of the β-sitosterol and stigmasterol powder presented shiny needle-like 
crystals, similar to previous research on phytosterols (AlHasawi & Rogers, 2013). The 
addition of stigmasterol into the FHSO:SO matrix caused morphological differences in the 
aggregated spherulite crystalline structure; long needle-like crystals arose as indicated in 
the powder stigmasterol sample. An apparent concentration difference between the higher 
concentration of β-sitosterol in the 25:23:52 β-Sit:FHSO:SO versus the 20:28:52 β-
Sit:FHSO:SO sample presented shiny flower-like β-sitosterol crystals as displayed in the 
pure β-Sitosterol. The addition of β-sitosterol did not seem to drastically modify the 
aggregated spherulite structure of the FHSO:SO matrix, but rather exhibited a trivial 
presence within the network.  
These results correspond to previous research in that the addition of phytosterol 
esters (PE) into milk fat (MF) did not seem to drastically modify the structure of MF 
crystals, nonetheless the PE still showed a small presence within the MF crystal network 
(Rodrigues, Torres, Mancini-Filho, & Gioielli, 2007). The inhabitance of both FPS, β-
sitosterol and stigmasterol, in the 10:10:28:52 β-Sit:Stig:FHSO:SO sample displayed a 
branch-like crystal structure differing from both the β-sitosterol and stigmasterol 
structures. Non-uniform structures were observed in all DIC FPS fat blend images. Previous 
research stated non-uniform crystal structures may be elucidated by FPS in the matrix 
impeding nucleation of the triacylglycerol crystals (Bouzidi et al., 2013). The addition of 
FPS into the matrix by impeding further nucleation and growth may be hindering 
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polymorphic transformations due to the viscosity of the matrix, as seen in XRD results 
(Figure 3.2) (Sato, 2001; Rousseau et al., 2005; Bouzidi et al., 2013). 
 
Figure 3.3 DIC microstructure of FPS powders, FPS fat blends and control 
 
3.4. Oil loss analysis 
Fat crystal networks possess physicochemical properties that bind and entrap oil 
(Acevedo et al., 2012). Oil loss (OL) in this study and previous studies has been determined 
through the measurement of the maximum oil loss over time, which is the mass of oil lost 
from the fat sample under controlled conditions (Dibildox-Alvarado et al., 2004; Acevedo et 
al., 2012; Bouzidi et al., 2013). Figure 3.4 reports OL values as a function of time and Figure 
3.5 reports OL rates in g/h. The 48:52 FHSO:SO control sample presented 41.52 ± 12.56% 
OL after reaching the plateau at about 1,000 h with an OL rate of 0.18 ± 0.09 g/h. While the 
FPS fat blends had OL values ranging from 28.07-46.00% and OL rates of 0.09-0.16 g/h. 
The addition of β-sitosterol into the FHSO:SO matrix at 20% decreased the amount of total 
OL compared to the control by 13.45% respectively. The decrease in OL % with lesser 
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FHSO conflicts with previous studies stating decreasing the FHSO leads to more oil loss 
over time (Acevedo et al., 2012).  
However, there is a lack of literature discussing the effects of FPS powders on OL % 
in FHSO:SO blends. According to previous research, two important parameters which 
successfully and predictively measure the relative tendency of a solid network to lose/hold 
oil were defined: (1) the rate of oil loss, which is a quantified representation of the kinetics 
of oil loss and (2) the initial amount of oil receptive to be lost, i.e., the propensity for oil loss 
(POL), which is a representation of the thermodynamics of oil binding (Bouzidi et al., 
2013). The initial amount of oil receptive to be lost is dependent upon how much oil is 
experimentally added to the system. 
Researchers suggested that the mechanism of oil binding is complex, depending on 
the structurant's crystalline form locked within the oil network (Bouzidi et al., 2013). 
Furthermore, the POL and oil loss rate values do not always trend in the same fashion, 
which coincides with the results from the addition of FPS into a FHSO:SO matrix. The 
control and all FPS samples had equal amounts of initial oil receptive to be lost (POL) at 
52% total weight of SO, yet the final OL values differed. These results suggest the addition 
of FPS have a thermodynamic effect on the system’s ability to lock oil within the network.  
OL % and OL rate analysis was conducted on commercial puff pastry shortening to 
ascertain the differences between FPS:FHSO:SO blends. Similar OL % resulted between 
20:28:52 β-Sito:FHSO:SO (28.07 ± 3.71%) and puff pastry shortening (29.80 ± 1.60%) over 
time. However, all FPS fat blends presented significantly lower OL rates (0.09-0.16 g/h) 
than puff pastry shortening (0.52 ± 0.09 g/h), suggesting the FPS fat blends may release oil 
at a slower rate, which would be desirable in shelf life (Figure 3.5).  
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Figure 3.4. Oil loss of control (a), FPS fat blends (b) and puff pastry shortening (c) as a 
function of time 
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Figure 3.5 Oil loss (OL) rate (g/h) from slope of OL as a function of time 
 
3.5. Solid fat content (SFC) analysis by pulsed nuclear magnetic resonance 
Solid fat content (SFC) analysis was conducted to determine the SFC profiles of all 
samples compared to commercial puff pastry shortening and SFC at room temperature 
(Figure 3.6a and b). SFC profile results from puff pastry shortening were in agreement with 
previous research ~24% SFC at 20°C (Ghotra, Dyal, & Narine, 2002) (Figure 3.6b). The 
control sample reached 0% SFC at 65-70°C, however FPS blends did not achieve 0% SFC 
even at temperatures higher than 65-70°C (Figure 3.6a).  
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Figure 3.6 Solid fat content (SFC) % melting profile (a) and SFC % at 20°C (b) 
 
This phenomenon could be due to a threshold in the co-crystallization of FPS with 
FHSO and SO; beyond a certain ratio of FPS with FHSO and SO not all of the FPS present 
may be co-crystallizing. There may be a phase separation of the components where some 
FPS did not integrate into the FSHO:SO matrix. XRD patterns of new d-values suggested co-
crystallization occurred. However, the more sensitive method of NMR indicated that 100% 
of FPS in the matrix are not co-crystallized.  
Previous research has been conducted on the addition of phytosterols into a matrix 
on SFC. However the work encompassed phytosterol esters (PE) blended with milk fat 
(MF), instead of FPS (Rodrigues et al., 2007). The MF PE blends presented a decrease in SFC 
when a higher proportion of PE was present, even though PE independently presented 
higher SFC than MF at all temperatures (Rodrigues et al., 2007). A phenomenon was 
hypothesized regarding the interaction between MF and PE in that the PE interfered with 
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the formation of a MF crystalline structure, resulting in lower SFC values (Rodrigues et al., 
2007). FPS may still have this effect on FHSO:SO crystalline structure, but at a lower 
percentage than 20-25% total weight of FPS. Results may be suggesting a threshold in the 
capability for the matrix to co-crystallize. At 20°C no differences were observed in SFC for 
the FPS blends, even though different types of FPS and different percentages were utilized 
(Figure 3.6b). The 20% versus 25% FPS and the β-sitosterol versus the stigmasterol were 
not significantly different. Therefore, it was proposed that the type or percentage of FPS did 
not affect the SFC at room temperature but the presence of FPS versus the FHSO did affect 
the SFC at room temperature as shown by significant differences between all FPS 
containing samples versus the control. Again, this may be due to a threshold in co-
crystallization where the percentage of FPS incorporated was beyond the threshold. 
 
3.6. Analysis of macro structural properties by small deformation oscillatory rheology 
Small deformation rheology with an oscillatory stress sweep was conducted in 
order to maintain a linear viscoelastic region (LVR) where measurements of G’ and G’’ were 
obtained. No significant differences were observed in the G’ values of the blends except for 
commercial puff pastry shortening and 25:23:52 β-Sit:FHSO:SO (Figure 3.7a). These results 
indicate the sample with a higher percentage of phytosterols (25% vs. 20%) and lower 
percentage of FHSO (23% vs. 28%) had similar properties, in regards to G’, as compared to 
commercial puff pastry shortening. G’ is the storage modulus which represents the elastic 
behavior of the sample (Marangoni & Wesdorp, 2013). G’ has been related to the strength 
or hardness and has also been a strong indicator of the SFC of the fat crystal network 
(Acevedo et al., 2012; Marangoni & Wesdorp, 2013).  
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Figure 3.7 G’ (a), G’’ (b) and yield stress (σ*) (c) at 20°C   
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Therefore, it is not surprising that the sample containing a lower proportion of 
FHSO at 23% (25:23:52 β-Sit:FHSO:SO) resulted in a lower G’ value as compared to the rest 
of the samples containing 28% FHSO.  
G’’ represents the viscosity of the fat crystal network also known as the loss 
modulus (Marangoni & Wesdorp, 2013). Similar to the aforementioned G’ results, there 
were no significant differences in G’’ between the 25:23:52 β-Sit:FHSO:SO sample and the 
commercial puff pastry shortening suggesting parallel viscoelastic properties (Figure 3.7b). 
Again, this may be related to the decrease in FHSO in the sample containing a higher 
proportion of phytosterols. 
The measurement of yield stress is one of the most imperative macroscopic 
properties in regards to assessing fats; it is strongly correlated to the sensory perception, 
material stability and spreadability (Marangoni & Wesdorp, 2013). Previous research 
states that if the yield stress for shortenings falls within the 200-800 Pa range, the product 
may be acceptable for bakery applications (Haighton, 1959). Not only did the puff pastry 
commercial shortening fall within this range, but so did all of the FPS:FHSO:SO samples 
(Figure 3.7c). Additionally, the 20:28:52 β-Sit:FHSO:SO sample and the commercial puff 
pastry shortening were not significantly different from each other in respect to yield stress 
values, suggesting analogous sensory, stability and spreadability characteristics. In puff 
pastry shortening applications, the shortening is layered between sheets of dough (Ghotra 
et al., 2002). In order to create separate flaky layers during the baking process it is 
imperative that replacements for puff pastry shortenings have similar spreadability 
(Ghotra et al., 2002).  
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The sample containing higher percentages of FPS at 25% had lower mechanical 
properties compared to samples containing lower percentages of FPS at 20%. This could be 
explained by incompatibilities between components of the FHSO:SO versus FPS systems 
(Marangoni & Wesdorp, 2013). Incompatibility within fat systems has previously been 
studied in chocolate; it has been correlated to the cause of undesirable chocolate blooming 
(Marangoni & Wesdorp, 2013). Perhaps the explanation for the lower mechanical 
properties is that, similar to the incompatibilities between cocoa butter and milk fat used in 
chocolate, the FPS are not compatible with the FHSO:SO matrix.  
 
4. Conclusions 
 The absence of peaks at higher temperatures of the FPS Tm suggested co-
crystallization by DSC. XRD patterns revealed the presence of new d-values not present in 
the control sample or in the FPS powders XRD patterns. These new d-values insinuated 
new structures present from the co-crystallization of FPS with triacylglycerols. Fat crystal 
networks were characterized as either spherulites for β-sitosterol or long needle-like 
structures for stigmasterol. Overall, the addition of FPS decreased the OL % of the matrix, 
which was comparable to commercial puff pastry shortening. In regards to SFC, the type of 
FPS (β-sitosterol or stigmasterol) and the percentage (20% or 25%) did not affect the SFC 
of the FPS blends at room temperature. However, the addition of FPS into the FHSO:SO 
matrix extended the melting profile compared to the control and commercial puff pastry 
shortening. The extended melting profile could affect how the FPS shortenings perform 
during baking. Furthermore, NMR may have detected a threshold in co-crystallization, the 
FPS shortenings did not achieve 0% SFC at the Tm of ~65°C reported in DSC thermograms. 
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Despite differences in SFC melting profiles, the rheological properties of the FPS enriched 
shortenings were comparable to those of commercial puff pastry shortening, notably all 
FPS shortenings fell within the 200-800 Pa range. With further research in regards to SFC 
melting profile and determining the threshold of co-crystallization, the FPS shortenings 
may be suitable for bakery applications and utilized as a desirable replacement for puff 
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 The overall objective of this research was to prepare a trans-fat free 
substitute for commercial shortenings typically consisting of partially hydrogenated 
fats, specifically puff pastry shortening. The prepared substitute was also enriched 
with free phytosterols adding previously studied health benefits such as lowering 
cholesterol and anti-cancer effects. Free phytosterols were utilized in order to 
reduce processing costs and inconvenience in the food industry. Phytosterol 
percentages were incorporated in high amounts of 20-25% as compared to other 
studies. WAXRD patterns and DSC suggested co-crystallization at these percentages, 
but NMR suggested the entire matrix was not co-crystallized. Oil loss and 
rheological values were comparable to commercial puff pastry shortening. Overall, 
this research demonstrated FPS FHSO:SO blends may be suitable for bakery 
applications due to comparative results amongst analyses with the blends and 











 Future research should focus on identifying the threshold at which the 
matrix can be 100% co-crystallized. This may allow for greater absorption of FPS 
during consumption if all the FPS were effectively entrapped and protected in the 
lipid system. A nutritional study would be beneficial to prove the absorption of FPS 
in this system. A range of percentages of FPS from low to high could be analyzed to 
compare differences in XRD patterns and NMR melting profiles. Furthermore, small 
angle x-ray diffraction should be conducted to further analyze the new structures 
suggested by WAXRD patterns. Cryo-TEM analyses could also be utilized to 
determine how the FPS and triacylglycerols are stacking within the lamella during 
the crystallization process. If necessary, emulsifiers could be added to the matrix to 
improve the equal dispersion of FPS with triacylglycerols. Sensory testing would 
also be appropriate in comparing puff pastries constructed with commercial puff 
pastry shortening versus puff pastries utilizing FPS enriched shortening. 
 
 
